Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/23/2003WO2003087774A2 Ecist microarrays for dual screening of dna hypermethylation and gene silencing
10/23/2003WO2003087772A2 Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells
10/23/2003WO2003087771A2 Method for making a molecularly smooth surface
10/23/2003WO2003087766A2 Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets
10/23/2003WO2003087765A2 System for tracing animal products
10/23/2003WO2003087763A2 Association of polymorphisms in the sost gene region with bone mineral density
10/23/2003WO2003087412A2 Mutation detection and identification
10/23/2003WO2003087410A1 Methods and devices for performing chemical reactions on a solid support
10/23/2003WO2003087409A1 Detection of polymorphisms
10/23/2003WO2003087408A2 Schizophrenia associated genes
10/23/2003WO2003087407A2 Methods and apparatus for genotyping
10/23/2003WO2003087406A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
10/23/2003WO2003087405A2 Method for characterizing primary tumors
10/23/2003WO2003087404A1 Methods to predict patient responsiveness to tyrosine kinase inhibitors
10/23/2003WO2003087403A2 Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases
10/23/2003WO2003087402A1 Method for the preparation of reagents for amplification and/or detection of nucleic acids that exhibit no significant contamination by nucleic acids
10/23/2003WO2003087401A1 High-density lipoprotein assay device and method
10/23/2003WO2003087400A1 Methods and reagents for assaying protein kinase activity
10/23/2003WO2003087399A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
10/23/2003WO2003087398A2 Electrochemical detector systems
10/23/2003WO2003087397A2 Process control based on microbiological activity
10/23/2003WO2003087396A1 Ex vivo method for determination of cetp activity and efficacy of heart disease treatment
10/23/2003WO2003087394A1 A method of identifying a modudator for a serine/theronine kinase
10/23/2003WO2003087391A2 Hydrophobic zone device
10/23/2003WO2003087390A2 Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples
10/23/2003WO2003087389A2 Biologic modulations with nanoparticles
10/23/2003WO2003087388A2 Bioluminescence regenerative cycle (brc) for nucleic acid quantification
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087365A1 Method of measuring human cyp3a inducibility
10/23/2003WO2003087362A1 Novel g protein-coupled receptor gene and protein bg8
10/23/2003WO2003087361A1 Method of selecting primer for dna synthesis
10/23/2003WO2003087360A1 Method of judging risk of arterial sclerosis, method of measuring risk of arterial sclerosis, microarray for judging risk of arterial sclerosis, device for judging risk of arterial sclerosis and program for judging risk of arterial sclerosis
10/23/2003WO2003087356A2 Helicokinin-receptor from insects
10/23/2003WO2003087353A2 Purified polypeptides involved in membrane biogenesis
10/23/2003WO2003087341A2 Targeted chromosomal mutagenesis using zinc finger nucleases
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087336A2 Estrogen receptor alpha regulated gene expression, related assays and therapeutics
10/23/2003WO2003087323A2 Biologic modulations with nanoparticles
10/23/2003WO2003087317A2 Methods for targeting quadruplex dna
10/23/2003WO2003087315A2 Pre-and post therapy gene expression profiling to identify drug targets
10/23/2003WO2003087309A2 Bdnf polymorphisms and association with bipolar disorder
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003087297A2 Infectious disease microarray
10/23/2003WO2003087293A1 Apparatus and method for biochemical analysis
10/23/2003WO2003087188A1 Oligonucleotide-modified romp polymers and co-polymers
10/23/2003WO2003087158A2 Regulation of human transient receptor potential channel
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087133A2 Improved methods for high-resolution identification of solvent-accessible amide hydrogens in polypeptides and for characterization of polypeptide structure
10/23/2003WO2003087132A2 Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity
10/23/2003WO2003087129A2 Immunogenic peptides, and method of identifying same
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087123A2 Methods and kits for testing mutagenicity
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087054A2 Methods for identifying compounds that modulate enzymatic activity
10/23/2003WO2003087051A2 Methods for identifying allosteric sites
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087021A2 Nanoparticle delivery systems and methods of use thereof
10/23/2003WO2003086478A1 Method and device for inactivating viruses
10/23/2003WO2003086473A1 Mycoplasma polypeptides
10/23/2003WO2003086461A2 Use of substances for treating tumors
10/23/2003WO2003086446A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003WO2003086374A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
10/23/2003WO2003086373A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086313A2 Methods for lightening skin and hair
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086299A2 Quantitative assay of the angiogenic and antiangiogenic activity of a test molecule
10/23/2003WO2003086292A2 Use of na,k-atpase a-and b-subunits in bladder cancer detection and drug screening
10/23/2003WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003WO2003086233A2 Thermal monitoring of tissue perfusion with recalibration.
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003086174A2 A new method for the diagnosis and prognosis of malignant diseases
10/23/2003WO2003072812A3 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
10/23/2003WO2003068947A8 Assay electrodes having immobilized lipid/protein layers and methods of making and using the same
10/23/2003WO2003066803A3 Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
10/23/2003WO2003065972A3 Methods for screening osteogenic compounds
10/23/2003WO2003064701A3 Method for the analysis of cytosine methylation patterns
10/23/2003WO2003060144A3 High fidelity dna polymerase compositions and uses therefor
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003054193A3 Raf/ras binding compounds
10/23/2003WO2003054005A3 Bone polypeptide-1
10/23/2003WO2003050242A3 Dna amplification and sequencing using dna molecules generated by random fragmentation
10/23/2003WO2003048773A3 Methods for monitoring amyotrophic lateral sclerosis
10/23/2003WO2003044217A3 Automated sample preparation methods and devices
10/23/2003WO2003040024A3 Assay based on doped nanoparticles
10/23/2003WO2003033663A3 Rankl mimics and uses thereof
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003025135A3 Genes associated with malignant neoplasms
10/23/2003WO2003020965A3 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight
10/23/2003WO2003020875A3 Staphylococci surface-exposed immunogenic polypeptides
10/23/2003WO2003020873A3 Reproduction of ribonucleic acids
10/23/2003WO2003018775A3 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays
10/23/2003WO2003018747A3 Molecular interaction sites of hepatitis c virus rna and methods of modulating the same
10/23/2003WO2003017755A3 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
10/23/2003WO2003016465A3 Cell cycle regulator protein
10/23/2003WO2003014382A3 Device for analyzing nucleic acid
10/23/2003WO2003010278A3 Automated process for detecting pathogenic organisms in water
10/23/2003WO2003008542A3 Nucleic acid detection assay control genes
10/23/2003WO2003000906A3 Plant disease resistance genes
1 ... 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 ... 3003